ID: ALA175307

Max Phase: Preclinical

Molecular Formula: C14H28N2O2

Molecular Weight: 256.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)CCCCCNCCCN1CCOCC1

Standard InChI:  InChI=1S/C14H28N2O2/c1-14(17)6-3-2-4-7-15-8-5-9-16-10-12-18-13-11-16/h15H,2-13H2,1H3

Standard InChI Key:  XJWQLOAYKJUVIF-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 256.39Molecular Weight (Monoisotopic): 256.2151AlogP: 1.45#Rotatable Bonds: 10
Polar Surface Area: 41.57Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.28CX LogP: 0.89CX LogD: -1.85
Aromatic Rings: 0Heavy Atoms: 18QED Weighted: 0.60Np Likeness Score: -0.73

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source